---
name: DrugBank Integration Complete - Next Steps
description: DrugBank fully wired; exploring new API additions (SwissADME, SciRouter, toxicology)
type: project
---

## Session Summary (2026-04-07)

### What We Accomplished

**DrugBank Full Integration - COMPLETE ✓**
- Wired `fetchDrugBankData()` into pharmaceutical category API route
- Converted DrugBankPanel from client-side fetch to server-side props
- Panel is now purely presentational (no useEffect, no loading states)
- Updated tests for new interface
- Fixed moleculeSummary.ts drugbank extraction
- Committed: `0e3df88`

**Data Flow (Option A - Server-Side Fetch):**
```
API Route → fetchDrugBankData(name) → returns { drug, targets, interactions }
         ↓
ProfilePageClient ← receives via /api/molecule/[id]/category/pharmaceutical
         ↓
DrugBankPanel ← receives data={d('drugbank')} as props
```

### What's Next - API Expansion Discussion

We started exploring new free APIs to add. Top candidates identified:

1. **SwissADME** - Drug-likeness predictions (Lipinski, Ghose, Veber, Egan filters). Free, no auth.
2. **pkCSM** - Pharmacokinetic/toxicity predictions
3. **SciRouter** - 50+ endpoints (ESMFold, AutoDock Vina, ADMET). 500 credits/month free.
4. **OpenTox** - Predictive toxicology, QSAR models
5. **bioRxiv API** - Preprint alerts

**User preference:** Excited about metabolism/ADME APIs and AI/ML platforms (SciRouter).

### Pending Tasks (Original Plan)

**Data Quality:**
- Task 4: Data freshness indicators
- Task 5: Source confidence scores
- Task 6: Cross-source conflict detection

**Technical Stability:**
- Task 7: Playwright E2E tests
- Task 8: Sentry error analytics
- Task 9: Performance monitoring

**API Expansion:** (new discussion)
- SwissADME, pkCSM, SciRouter, OpenTox, bioRxiv

---

## How to Resume

User will say "let's continue" or similar. Pick up with:
1. Either finish original plan (data quality + stability tasks)
2. Or start new API integrations (SwissADME first - free, no auth)

User is highly engaged with bioengineering vision. Keep momentum on API additions if that's what excites them.
